Heart Disease Clinical Trials in Dallas

Showing 61-80 of 219 trials

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

NCT02791880

In the last decade, transcatheter aortic valve replacement (TAVR) has become an increasingly utilized alternative procedure for replacing a stenotic aortic valve. This study collects clinical information, DNA, blood and urine samples (throughout procedural hospitalization) in order to investigate the incidence of acute kidney injury (AKI) in patients undergoing TAVR and to identify key clinical and procedural predictors of AKI. This study seeks to identify blood and urine biomarkers that can be used for early detection of AKI around the time of the procedure. The study seeks to assess for novel genetic variants associated with development of AKI after TAVR. Finally the study seeks to assess for novel genetic variants and biomarkers that are associated with adverse cardiovascular events after TAVR and to further explore how these events may inter-relate with acute kidney injury.

Acute Kidney InjuryRenal Insufficiency, ChronicHeart Failure+3 more

University of Texas Southwestern Medical Center62 participantsStarted Oct 2016

Dallas, Texas, United States • Dallas, Texas, United States • Dallas, Texas, United States

COMPLETEDNA< 1 mile

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

NCT06062329

Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism

Acute Pulmonary EmbolismThromboembolismEmboli, Pulmonary+5 more

Imperative Care, Inc.109 participantsStarted Dec 2023

Huntsville, Alabama, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +16 more locations

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

Heart Disease Trials in Other Cities

Global Utilization And Registry Database for Improved heArt preservatioN

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.

Carmat TAH Early Feasibility Study

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Hybrid Coronary Revascularization Trial

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

FUnctional diagnoSIs of corONary Stenosis (FUSION)

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Advancing Understanding of Transportation Options

Communication During Hospitalization About Resuscitation Trial

Other Conditions in Dallas